Phase I trial to evalaute the effects of a single dose of MEM 63908 in elderly volunteers

Trial Profile

Phase I trial to evalaute the effects of a single dose of MEM 63908 in elderly volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Jan 2010

At a glance

  • Drugs Facinicline (Primary)
  • Indications Alzheimer's disease
  • Focus Adverse reactions
  • Sponsors Memory Pharmaceuticals
  • Most Recent Events

    • 26 Sep 2008 Top-line results are expected from the full phase I program in quarter 4 2008, as reported in a Memory Pharmaceuticals media release.
    • 26 Sep 2008 Status changed from recruiting to completed as reported in a Memory Pharmaceuticals media release.
    • 06 Mar 2008 Status changed from planning to recruiting, according to a Memory Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top